Effects and Clinical Significance of GII.4 Sydney Norovirus, United States, 2012–2013

Eyal Leshem,Mary Wikswo,Leslie Barclay,Eric Brandt,William Storm,Ellen Salehi,Traci DeSalvo,Tim Davis,Amy Saupe,Ginette Dobbins,Hillary A Booth,Christianne Biggs,Katie Garman,Amy M Woron,Umesh D Parashar,Jan Vinjé,Aron J Hall,Hillary A. Booth,Amy M. Woron,Umesh D. Parashar,Aron J. Hall
DOI: https://doi.org/10.3201/eid1908.130458
IF: 16.126
2013-08-01
Emerging Infectious Diseases
Abstract:During 2012, global detection of a new norovirus (NoV) strain, GII.4 Sydney, raised concerns about its potential effect in the United States. We analyzed data from NoV outbreaks in 5 states and emergency department visits for gastrointestinal illness in 1 state during the 2012-13 season and compared the data with those of previous seasons. During August 2012-April 2013, a total of 637 NoV outbreaks were reported compared with 536 and 432 in 2011-2012 and 2010-2011 during the same period. The proportion of outbreaks attributed to GII.4 Sydney increased from 8% in September 2012 to 82% in March 2013. The increase in emergency department visits for gastrointestinal illness during the 2012-13 season was similar to that of previous seasons. GII.4 Sydney has become the predominant US NoV outbreak strain during the 2012-13 season, but its emergence did not cause outbreak activity to substantially increase from that of previous seasons.
immunology,infectious diseases
What problem does this paper attempt to address?